• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重度血友病和靶关节对健康相关生活质量的影响。

The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.

机构信息

Faculty of Health and Social Care, University of Chester, Chester, UK.

HCD Economics, Daresbury, UK.

出版信息

Health Qual Life Outcomes. 2018 May 2;16(1):84. doi: 10.1186/s12955-018-0908-9.

DOI:10.1186/s12955-018-0908-9
PMID:29720192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5932770/
Abstract

BACKGROUND

Joint damage remains a major complication associated with haemophilia and is widely accepted as one of the most debilitating symptoms for persons with severe haemophilia. The aim of this study is to describe how complications of haemophilia such as target joints influence health-related quality of life (HRQOL).

METHODS

Data on hemophilia patients without inhibitors were drawn from the 'Cost of Haemophilia across Europe - a Socioeconomic Survey' (CHESS) study, a cost-of-illness assessment in severe haemophilia A and B across five European countries (France, Germany, Italy, Spain, and the UK). Physicians provided clinical and sociodemographic information for 1285 adult patients, 551 of whom completed corresponding questionnaires, including EQ-5D. A generalised linear model was developed to investigate the relationship between EQ-5D index score and target joint status (defined in the CHESS study as areas of chronic synovitis), adjusted for patient covariates including socio-demographic characteristics and comorbidities.

RESULTS

Five hundred and fifteen patients (42% of the sample) provided an EQ-5D response; a total of 692 target joints were recorded across the sample. Mean EQ-5D index score for patients with no target joints was 0.875 (standard deviation [SD] 0.179); for patients with one or more target joints, mean index score was 0.731 (SD 0.285). Compared to having no target joints, having one or more target joints was associated with lower index scores (average marginal effect (AME) -0.120; SD 0.0262; p < 0.000).

CONCLUSIONS

This study found that the presence of chronic synovitis has a significant negative impact on HRQOL for adults with severe haemophilia. Prevention, early diagnosis and treatment of target joints should be an important consideration for clinicians and patients when managing haemophilia.

摘要

背景

关节损伤仍是血友病相关的主要并发症,也是严重血友病患者致残的主要症状之一。本研究旨在描述血友病相关并发症(如靶关节)如何影响健康相关生活质量(HRQOL)。

方法

本研究数据来源于“欧洲血友病成本调查-社会经济学评估”(CHESS)研究,该研究为在法国、德国、意大利、西班牙和英国五国开展的严重血友病 A 和 B 的疾病经济负担评估,纳入了无抑制剂的血友病患者。医生为 1285 名成年患者提供了临床和社会人口学信息,其中 551 名患者完成了相应的问卷,包括 EQ-5D。为研究 EQ-5D 指数评分与靶关节状态(CHESS 研究中定义为慢性滑膜炎区域)之间的关系,我们建立了广义线性模型,调整了患者协变量,包括社会人口统计学特征和合并症。

结果

共 515 名患者(样本的 42%)提供了 EQ-5D 评分;样本中共记录了 692 个靶关节。无靶关节患者的 EQ-5D 指数平均得分为 0.875(标准差[SD] 0.179);有 1 个或多个靶关节的患者指数平均得分为 0.731(SD 0.285)。与无靶关节相比,有 1 个或多个靶关节与较低的指数评分相关(平均边际效应(AME)-0.120;SD 0.0262;p<0.000)。

结论

本研究发现,慢性滑膜炎的存在对严重血友病成人的 HRQOL 有显著的负面影响。预防、早期诊断和治疗靶关节应成为临床医生和患者管理血友病时的重要考虑因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/352e305eb2d9/12955_2018_908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/d71462fb5610/12955_2018_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/79c33a632844/12955_2018_908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/6fe6241b4c45/12955_2018_908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/352e305eb2d9/12955_2018_908_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/d71462fb5610/12955_2018_908_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/79c33a632844/12955_2018_908_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/6fe6241b4c45/12955_2018_908_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9409/5932770/352e305eb2d9/12955_2018_908_Fig4_HTML.jpg

相似文献

1
The impact of severe haemophilia and the presence of target joints on health-related quality-of-life.重度血友病和靶关节对健康相关生活质量的影响。
Health Qual Life Outcomes. 2018 May 2;16(1):84. doi: 10.1186/s12955-018-0908-9.
2
Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.真实世界中血友病 A 和血友病 B 患者出血并发症及健康相关生活质量的对比分析。
Haemophilia. 2018 Sep;24(5):e322-e327. doi: 10.1111/hae.13596. Epub 2018 Aug 9.
3
Exploring the relationship between condition severity and health-related quality of life in people with haemophilia A across Europe: a multivariable analysis of data from the CHESS II study.探讨欧洲血友病 A 患者病情严重程度与健康相关生活质量之间的关系:CHESS II 研究数据的多变量分析。
Health Qual Life Outcomes. 2024 Jul 29;22(1):58. doi: 10.1186/s12955-024-02267-6.
4
Social/economic costs and quality of life in patients with haemophilia in Europe.欧洲血友病患者的社会/经济成本与生活质量
Eur J Health Econ. 2016 Apr;17 Suppl 1:53-65. doi: 10.1007/s10198-016-0785-2. Epub 2016 Apr 5.
5
The relationship between target joints and direct resource use in severe haemophilia.重度血友病中目标关节与直接资源利用之间的关系。
Health Econ Rev. 2018 Jan 16;8(1):1. doi: 10.1186/s13561-018-0185-7.
6
Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study.五项欧洲国家非抑制性血友病 A 的临床与人文负担:来自 CHESS II 研究的洞察。
Adv Ther. 2024 Oct;41(10):3888-3904. doi: 10.1007/s12325-024-02956-0. Epub 2024 Aug 17.
7
Examining the impact of haemophilia treatment on health-related quality of life.探讨血友病治疗对健康相关生活质量的影响。
Haemophilia. 2022 Sep;28(5):796-805. doi: 10.1111/hae.14583. Epub 2022 May 10.
8
No difference in quality of life between persons with severe haemophilia A and B.重型 A 型和 B 型血友病患者的生活质量无差异。
Haemophilia. 2023 Jul;29(4):987-996. doi: 10.1111/hae.14759. Epub 2023 Feb 15.
9
Clinical, humanistic, and economic burden of severe haemophilia B in adults receiving factor IX prophylaxis: findings from the CHESS II real-world burden of illness study in Europe.成人接受因子 IX 预防治疗的重度 B 型血友病的临床、人文和经济负担:来自欧洲 CHESS II 真实世界疾病负担研究的结果。
Orphanet J Rare Dis. 2021 Dec 20;16(1):521. doi: 10.1186/s13023-021-02152-1.
10
Assessment of joint health in patients receiving prophylaxis for haemophilia A: a cross-sectional survey in five European countries.评估接受甲型血友病预防治疗患者的关节健康状况:五个欧洲国家的横断面调查。
BMJ Open. 2024 Sep 10;14(9):e082204. doi: 10.1136/bmjopen-2023-082204.

引用本文的文献

1
Clinical Burden and Healthcare Resource Use Among Adults Living with Hemophilia A: An Observational Study.血友病A成年患者的临床负担与医疗资源利用:一项观察性研究
Drugs Real World Outcomes. 2025 Sep 1. doi: 10.1007/s40801-025-00516-8.
2
A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders.遗传性出血性疾病治疗经济评估中建模方法的系统评价
Appl Health Econ Health Policy. 2025 Aug 31. doi: 10.1007/s40258-025-00996-3.
3
TSUBASA study: evaluation of the quality and content of daily life of people with hemophilia A without factor VIII inhibitors on prophylactic treatment with emicizumab.

本文引用的文献

1
The relationship between target joints and direct resource use in severe haemophilia.重度血友病中目标关节与直接资源利用之间的关系。
Health Econ Rev. 2018 Jan 16;8(1):1. doi: 10.1186/s13561-018-0185-7.
2
Prophylaxis usage, bleeding rates, and joint outcomes of hemophilia, 1999 to 2010: a surveillance project.1999年至2010年血友病的预防用药、出血率及关节转归:一项监测项目
Blood. 2017 Apr 27;129(17):2368-2374. doi: 10.1182/blood-2016-02-683169. Epub 2017 Feb 9.
3
Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
TSUBASA研究:评估接受emicizumab预防性治疗的无因子VIII抑制剂的A型血友病患者的生活质量和日常生活内容。
Res Pract Thromb Haemost. 2025 Jul 16;9(5):102971. doi: 10.1016/j.rpth.2025.102971. eCollection 2025 Jul.
4
The association of factor VIII activity levels with bleeding and quality of life in haemophilia a: findings from the European CHESS II study.血友病A中凝血因子VIII活性水平与出血及生活质量的关联:欧洲CHESS II研究的结果
Orphanet J Rare Dis. 2025 Jun 3;20(1):272. doi: 10.1186/s13023-025-03699-z.
5
Global trends in hemophilic arthropathy research: a bibliometric and visualization analysis.血友病性关节病研究的全球趋势:文献计量与可视化分析
Front Med (Lausanne). 2025 Apr 16;12:1556906. doi: 10.3389/fmed.2025.1556906. eCollection 2025.
6
Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in People Living With Severe Hemophilia A : A Cost-Effectiveness Analysis.预防性每周一次艾美赛珠单抗α与标准护理因子VIII用于重度A型血友病患者的成本效益分析
Ann Intern Med. 2025 Jun;178(6):819-828. doi: 10.7326/ANNALS-24-02749. Epub 2025 Apr 22.
7
Treatment of Bleeding Episodes With Efanesoctocog Alfa in Previously Treated Patients With Severe Hemophilia A in the Phase 3 XTEND-1 Study.在3期XTEND-1研究中,使用阿法依那索单抗治疗既往接受过治疗的重度A型血友病患者的出血发作情况。
Am J Hematol. 2025 May;100(5):813-820. doi: 10.1002/ajh.27603. Epub 2025 Feb 10.
8
An assessment of burden associated with problem joints in children and adults with moderate or severe haemophilia A: analysis of the CHESS-Paediatrics and CHESS II cross-sectional studies.对中重度甲型血友病儿童和成人中问题关节相关负担的评估:CHESS-儿科和CHESS II横断面研究分析
Orphanet J Rare Dis. 2025 Jan 13;20(1):18. doi: 10.1186/s13023-024-03514-1.
9
Cost-effectiveness of Voncento prophylaxis vs on-demand treatment in von Willebrand disease in the United Kingdom.在英国,冯·威勒布兰德病中使用冯森托预防疗法与按需治疗的成本效益分析
Blood Adv. 2025 Mar 25;9(6):1312-1319. doi: 10.1182/bloodadvances.2024014376.
10
Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies.英国血友病相关费用的分布和预测因素:CHESS I 和 CHESS II 疾病负担研究分析。
BMC Health Serv Res. 2024 Nov 20;24(1):1437. doi: 10.1186/s12913-024-11850-y.
使用EQ-5D-5L量表测量的健康相关生活质量:南澳大利亚州人群常模。
Health Qual Life Outcomes. 2016 Sep 20;14(1):133. doi: 10.1186/s12955-016-0537-0.
4
Optimal management of hemophilic arthropathy and hematomas.血友病性关节病和血肿的最佳管理。
J Blood Med. 2014 Oct 17;5:207-18. doi: 10.2147/JBM.S50644. eCollection 2014.
5
Switching treatments in haemophilia: is there a risk of inhibitor development?血友病治疗的转换:是否存在产生抑制物的风险?
Eur J Haematol. 2015 Apr;94(4):284-9. doi: 10.1111/ejh.12433. Epub 2014 Sep 17.
6
Definitions in hemophilia: communication from the SSC of the ISTH.血友病的定义:来自国际血栓与止血学会(ISTH)科学标准化委员会(SSC)的交流文件
J Thromb Haemost. 2014 Nov;12(11):1935-9. doi: 10.1111/jth.12672. Epub 2014 Sep 3.
7
The social burden and quality of life of patients with haemophilia in Italy.意大利血友病患者的社会负担与生活质量
Blood Transfus. 2014 Apr;12 Suppl 3(Suppl 3):s567-75. doi: 10.2450/2014.0042-14s.
8
Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population.比较 EQ-5D 3L 和 5L:在普通人群中与慢性疾病和多种疾病的测量特性及相关性。
Health Qual Life Outcomes. 2014 May 16;12:74. doi: 10.1186/1477-7525-12-74.
9
Factor IX deficiency (Christmas disease).因子IX缺乏症(克里斯马斯病)。
Med J Armed Forces India. 2012 Oct;68(4):379-80. doi: 10.1016/j.mjafi.2011.12.007. Epub 2012 Aug 15.
10
Evaluating direct medical expenditures estimation methods of adults using the medical expenditure panel survey: an example focusing on head and neck cancer.利用医疗支出面板调查评估成年人直接医疗支出估计方法:以头颈部癌症为例。
Value Health. 2014 Jan-Feb;17(1):90-7. doi: 10.1016/j.jval.2013.10.004.